H. Joseph Reiser

H. Joseph Reiser, Ph.D., has more than 38 years of pharmaceutical and biotech experience in both public and private companies. In large pharma, Dr. Reiser was Corporate Vice President and General Manager, Pharmaceuticals, and a member of the Board of Directors for Berlex Laboratories, the U.S. subsidiary of Schering AG (now Bayer AG). During his 17 year tenure at Berlex, Dr. Reiser held numerous senior leadership positions, including President of Schering Berlin’s Venture Corporation, Vice President, Technology and Industry Relations, and Vice President, Drug Development. In the biotech space, Dr. Reiser led or founded 7 biotech companies including 2 NASDAQ-listed public companies, CYTOGEN and Cortendo AB (now StrongBridge), and 5 private companies including Mito Biopharma where he serves as President and CEO and member of the Board. Dr. Reiser has served on numerous boards and has served as Board Chairman of three companies, more recently Complexa Inc., a clinical-stage platform company focusing on fibrosis and inflammation. Dr. Reiser has also served as Chairman of the New Jersey Biotechnology Council from 2001 to 2002 and concluded a six-year tenure as a member of the Board and Executive Committee of the Pennsylvania Biotech Association. Dr. Reiser received his Masters and Ph.D. in Physiology from Indiana University School of Medicine and earned a Bachelor of Science degree from Indiana University. Dr. Reiser has been serving Mito BioPharma in various capacity including CEO, Board Member, and Executive Consultant.